Paediatric HIV infection

Lancet

Volumn 348, Issue 9031, 1996, Pages 863-868

  Scarlatti, Gabriella ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHILDHOOD DISEASE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MOTHER; NEWBORN; PREGNANCY; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROLOGY; SHORT SURVEY; VERTICAL TRANSMISSION; VIROLOGY; VIRUS TRANSMISSION;

EID: 0030604911     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)11030-5     Document Type: Review

References (50)

1. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 1991; 337: 253-60.
2. Simonon A, Lepage P, Karita E, et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. J AIDS 1994; 7: 952-57.
3. Dabis F, Msellati P, Dunn D, et al. Estimating the rate of mother-to-child transmission of HIV: report of a workshop on methodological issues, Ghent (Belgium). AIDS 1993; 7: 1139-48.
4. Courgnaud V, Laure F, Broussard A, et al. Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses 1991; 7: 337-41.
5. Viscarello RR, Cullen MT, DeGennaro NJ, et al. Fetal blood sampling in human immunodeficiency virus-seropositive women before elective midtrimester termination of pregnancy. Am J Obstet Gynecol 1992; 167: 1075-79.
6. Goedert J, Dulliege A-M, Amos C, et al. High risk of HIV-1 infection for first-born twins. Lancet 1991; 338: 1471-75.
7. De Rossi A, Zanotto C, Mammano F, et al. Patterns of antibody response against the V3 loop in children with vertically acquired human immunodeficiency virus type 1 (HIV-1) infection. AIDS Res Hum Retroviruses 1993; 8: 221-28.
8. Rouzioux C, Costagliola D, Burgard M, et al. Timing of mother-to-child transmission depends on maternal status. AIDS 1993; 7: S49-52.
9. Bryson YJ, Luzuriaga K, Sullivan JL, et al. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992; 327: 1246-47.
10. Langston C, Lewis DE, Hammill HA, et al. Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection. J Infect Dis 1995; 172: 1451-60.
11. Dunn DT, Newell ML, Ades AE, et al. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992; 340: 585-88.
12. World Health Organisation. Global Programme on AIDS: consensus statement from WHO/UNICEF consultation on HIV transmission and breast-feeding. Wkly Epidemiol Rec 1992; 67: 177-79.
13. Lewis SH, Reynolds-Kohler C, Fox HE, Newton JA. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet 1990; 335: 565-68.
14. Henin Y, Mandelbrot L, Henrion Ret al. HIV in the cervicovaginal secretions of pregnant and non-pregnant women. J AIDS. 6:1993;72-75.
15. Batman PA, Fleming SC, Sedgwick PM, et al. HIV infection of human fetal intestinal explant cultures induces epithelial cell proliferation. AIDS 1994; 8: 161-67.
16. Scarlatti G, Leitner T, Halapi E, et al. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci USA 1993; 90: 1721-25.
17. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992; 339: 1007-12.
18. Tovo P-A, Palomba E, Gabbiano C, et al. Human immunodeficiency virus type 1 (HIV-1) seroconversion during pregnancy does not increase the risk of perinatal transmission. Br J Obstet Gynaecol 1991; 98: 940-42.
19. Centers for Disease Control. Zidovudine for the prevention of HIV transmission from mother to infant. Morbid Mortal Wkly Rep 1994; 43: 285-87.
20. Fang G, Burger H, Grimson R, et al. Maternal plasma human immunodeficiency virus type 1 RNA levels: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995; 92: 12100-04.
21. Kliks SC, Wara DW, Landers DV, et al. Features of HIV-1 that could influence maternal-child transmission. J AMA 1994; 272: 467-74.
22. Scarlatti G, Hodara V, Rossi P, et al. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother-to-child correlates with viral phenotype. Virology 1993; 197: 624-29.
23. Rossi P, Moschese V, Broliden PA, et al. Presence of antibodies to HIV-1 gp 120 env epitopes correlates with uninfected status of the children born to seropositive mothers. Proc Natl Acad Sci USA 1989; 86: 8055-58.
24. Parekh BS, Shaffer N, Chou-Pong P, et al. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. AIDS 1991; 5: 1179-84.
25. Scarlatti G, Albert J, Rossi P, et al. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis 1993; 168: 207-10.
26. Bryson YJ, Pang S, Wei LS, et al. Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995; 332: 833-38.
27. Roques PA, Gras G, Parnet-Mathieu F, et al. Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS 1995; 9: F19-26.
28. Newell M-L, Dunn D, De Maria A, et al. Detection of virus in vertically exposed HIV-antibody-negative children. Lancet 1996; 347: 213-15.
29. Clerici M, Sison AV, Berzoisky JA, et al. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 1993; 7: 1427-33.
30. Rowland-Jones SL, Nixon DF, Aldhous MC, et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993; 341: 860-61.
31. Borkowsky W, Krasinski K, Moore T, et al. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children. AIDS Res Hum Retroviruses 1990; 6: 673-78.
32. Ometto L, Zanotto C, Maccabruni A, et al. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS 1995; 9: 427-34.
33. Biggar RJ, Miotti PG, Taka TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996; 343: 1647-50.
34. European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994; 343: 1464-67.
35. Rogers MF, Ou C, Kilbourne B, et al. Advances and problems in the diagnosis of human immunodeficiency virus infection infants. Pediatr Infect Dis J 1991; 10: 523-31.
36. Report of a Consensus Workshop, S. Italy. Early diagnosis of HIV infection in infants. J AIDS 1992; 5: 1169-78.
37. Borkowsky W, Krasinski K, Pollack H, et al. Early diagnosis of human immunodeficiency virus infection in children <6 months of age: comparison of polymerase chain reaction, culture, and plasma antigen capture techniques. J Infect Dis 1992; 166: 616-19.
38. Miles SA, Balden E, Magpantay L, et al. Rapid serologic testing with immune-complex dissociated HIV p24 antigen for early detection of HIV in neonates. N Engl J Med 1993; 328: 297-302.
39. Schüpbach J, Wunderli W, Kind C, et al. Frequent detection of HIV- and IgG-specific IgM and IgA antibodies in HIV-positive cord-blood sera: fine analysis by western blot. AIDS 1989; 3: 583-89.
40. Amadori A, De Rossi A, Giaquinto C, Faulkner-Valle G, Zocchello F, Chiecto-Brianchi L. In-vitro production of HIV-specific antibodies in children at risk of AIDS. Lancet 1988; i: 852-54.
41. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989; 321: 1791-96.
42. Tovo PA, DeMartino M, Gabiano C, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992; 339: 1249-53.
43. European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus. Pediatrics 1994; 94: 815-19.
44. Galli L, de Martino M, Tovo P-A, et al. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 1995; 9: 445-61.
45. Centers for Disease Control and Prevention Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. Morbid Mortal Wkly Rep. 44:1995;1-11.
46. Working Group on Antiretroviral Therapy, National Pediatric HIV Resource Center Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Pediatr Infect Dis J. 12:1993;13-22.
47. Centers for Disease Control 1994 Revised Classification System for Human Immunodeficiency Virus Infection in Children Less Than 13 years of Age. Morbid Mortal Wkly Rep. 43:1994;1-10.
48. De Rossi A, Giaquinto C, Ometto L, et al. Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J Pediatr 1993; 123: 929-36.
49. Palumbo PE, Kwok S, Waters S, et al. Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants. J Pediatr 1995; 126: 592-95.
50. Robert-Guroff M, Oleske JM, O'Connor EM, Epstein LG, Minnefor AB, Gallo RC. Relationship between HTLV-III neutralising antibodies and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases. Pediatr Res 1987; 21: 547-50.